290 related articles for article (PubMed ID: 29189345)
21. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: A time-dependent analysis.
Lin KY; Chen PY; Chuang YC; Wang JT; Sun HY; Sheng WH; Chen YC; Chang SC
J Infect; 2018 Sep; 77(3):242-248. PubMed ID: 29932963
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.
Colombo AL; Guimarães T; Sukienik T; Pasqualotto AC; Andreotti R; Queiroz-Telles F; Nouér SA; Nucci M
Intensive Care Med; 2014 Oct; 40(10):1489-98. PubMed ID: 25082359
[TBL] [Abstract][Full Text] [Related]
24. Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.
Kett DH; Shorr AF; Reboli AC; Reisman AL; Biswas P; Schlamm HT
Crit Care; 2011; 15(5):R253. PubMed ID: 22026929
[TBL] [Abstract][Full Text] [Related]
25. Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients.
Reboli AC; Rotstein C; Kett DH; Maschio M; Cartier S; Chambers R; Tarallo M
Pharmacoeconomics; 2011 Aug; 29(8):705-17. PubMed ID: 21591820
[TBL] [Abstract][Full Text] [Related]
26. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
27. Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites-United States, 2017-2018.
Gold JAW; Seagle EE; Nadle J; Barter DM; Czaja CA; Johnston H; Farley MM; Thomas S; Harrison LH; Fischer J; Pattee B; Mody RK; Phipps EC; Davis SS; Tesini BL; Zhang AY; Markus TM; Schaffner W; Lockhart SR; Vallabhaneni S; Jackson BR; Lyman M
Clin Infect Dis; 2021 Nov; 73(9):1609-1616. PubMed ID: 34079987
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common
Kim JH; Suh JW; Kim MJ
J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233250
[TBL] [Abstract][Full Text] [Related]
29. Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole.
Heimann SM; Cornely OA; Wisplinghoff H; Kochanek M; Stippel D; Padosch SA; Langebartels G; Reuter H; Reiner M; Vierzig A; Seifert H; Vehreschild MJ; Glossmann J; Franke B; Vehreschild JJ
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):331-8. PubMed ID: 25213718
[TBL] [Abstract][Full Text] [Related]
30. Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU.
Bruyère R; Quenot JP; Prin S; Dalle F; Vigneron C; Aho S; Leon C; Charles PE
BMC Infect Dis; 2014 Jul; 14():385. PubMed ID: 25015848
[TBL] [Abstract][Full Text] [Related]
31. Mortality and risk factor analysis for Candida blood stream infection: A multicenter study.
Kato H; Yoshimura Y; Suido Y; Shimizu H; Ide K; Sugiyama Y; Matsuno K; Nakajima H
J Infect Chemother; 2019 May; 25(5):341-345. PubMed ID: 30718191
[TBL] [Abstract][Full Text] [Related]
32. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
33. Impact of initial empirical antifungal agents on the outcome of critically ill patients with invasive candidiasis: analysis of the China-SCAN study.
Cui N; Wang H; Qiu H; Li R; Liu D
Int J Antimicrob Agents; 2017 Jul; 50(1):74-80. PubMed ID: 28499959
[TBL] [Abstract][Full Text] [Related]
34. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
Tagliaferri E; Menichetti F
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
[TBL] [Abstract][Full Text] [Related]
35. Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards.
Mazzanti S; Brescini L; Morroni G; Orsetti E; Pocognoli A; Donati A; Cerutti E; Munch C; Montalti R; Barchiesi F
PLoS One; 2021; 16(5):e0252165. PubMed ID: 34038468
[TBL] [Abstract][Full Text] [Related]
36. Attributable mortality of candidemia after introduction of echinocandins.
Cornely FB; Cornely OA; Salmanton-García J; Koehler FC; Koehler P; Seifert H; Wingen-Heimann S; Mellinghoff SC
Mycoses; 2020 Dec; 63(12):1373-1381. PubMed ID: 32885534
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study.
Jia X; Li C; Cao J; Wu X; Zhang L
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1717-1724. PubMed ID: 30030692
[TBL] [Abstract][Full Text] [Related]
38. Candidemia in children.
Zaoutis T
Curr Med Res Opin; 2010 Jul; 26(7):1761-8. PubMed ID: 20513207
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
40. Impact of infectious diseases consultation as a part of an antifungal stewardship programme on candidemia outcome in an Italian tertiary-care, University hospital.
Menichetti F; Bertolino G; Sozio E; Carmignani C; Rosselli Del Turco E; Tagliaferri E; Sbrana F; Ripoli A; Barnini S; Desideri I; Dal Canto L; Tascini C;
J Chemother; 2018 Sep; 30(5):304-309. PubMed ID: 30843776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
